These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19791315)

  • 21. Injecting Safety into Supplements - Modernizing the Dietary Supplement Law.
    Cohen PA; Bass S
    N Engl J Med; 2019 Dec; 381(25):2387-2389. PubMed ID: 31851798
    [No Abstract]   [Full Text] [Related]  

  • 22. PLIVA v. Mensing: generic consumers' unfortunate hand.
    Lee SB
    Yale J Health Policy Law Ethics; 2012; 12(2):209-63. PubMed ID: 23175916
    [No Abstract]   [Full Text] [Related]  

  • 23. Pin the tail on the other donkey: allocating and avoiding injury losses after drug or device approval.
    O'Reilly JT
    Food Drug Law J; 2007; 62(3):559-72. PubMed ID: 17915397
    [No Abstract]   [Full Text] [Related]  

  • 24. Accidental intra-arterial injection of promethazine HCl during general anesthesia: report of a case.
    Mostafavi H; Samimi M
    Anesthesiology; 1971 Dec; 35(6):645-6. PubMed ID: 5124747
    [No Abstract]   [Full Text] [Related]  

  • 25. Prescription for fairness: a new approach to tort liability of brand-name and generic drug manufacturers.
    Rostron A
    Duke Law J; 2011 Feb; 60(5):1123-91. PubMed ID: 21365961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Duty to Warn.
    Clark JR
    Air Med J; 2018; 37(4):229-230. PubMed ID: 29935699
    [No Abstract]   [Full Text] [Related]  

  • 27. Wyeth preemption case ruling sparks labeling confusion.
    Allison M
    Nat Biotechnol; 2009 May; 27(5):399-400. PubMed ID: 19430423
    [No Abstract]   [Full Text] [Related]  

  • 28. FDA's regulation of prescription drug labeling: a role for implied preemption.
    Kendrick LC
    Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031
    [No Abstract]   [Full Text] [Related]  

  • 29. The National Childhood Vaccine Injury Act and the supreme court's interpretation.
    Blake V
    Virtual Mentor; 2012 Jan; 14(1):31-4. PubMed ID: 23116914
    [No Abstract]   [Full Text] [Related]  

  • 30. A defense of the learned intermediary doctrine.
    Goetz RB; Growdon KR
    Food Drug Law J; 2008; 63(2):421-38. PubMed ID: 18561470
    [No Abstract]   [Full Text] [Related]  

  • 31. Bad medicine: prescription drugs, preemption, and the potential for a no-fault fix.
    Smirniotopoulos A
    Rev Law Soc Change; 2012; 35(4):793-862. PubMed ID: 22363960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmaceutical industry wins "round one" in protections against product liability claims.
    Gatty B
    Hosp Formul; 1995 Apr; 30(4):238, 237. PubMed ID: 10141868
    [No Abstract]   [Full Text] [Related]  

  • 33. The case for preemption of prescription drug failure-to-warn claims.
    Kim CH
    Food Drug Law J; 2007; 62(2):399-422. PubMed ID: 17632969
    [No Abstract]   [Full Text] [Related]  

  • 34. Data-mining law struck down. Supreme court sides with drug companies in Vermont ruling.
    Carlson J
    Mod Healthc; 2011 Jun; 41(26):8-9. PubMed ID: 21853604
    [No Abstract]   [Full Text] [Related]  

  • 35. Off-label or out of bounds? Prescriber and marketer liability for unapproved uses of FDA-approved drugs.
    O'Reilly J; Dalal A
    Ann Health Law; 2003; 12(2):295-324, table of contents. PubMed ID: 12856461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Science and the Supreme Court: Cases to watch in 2018.
    Reardon S
    Nature; 2018 Oct; 562(7726):175. PubMed ID: 30301986
    [No Abstract]   [Full Text] [Related]  

  • 37. On access and accountability--two Supreme Court rulings on generic drugs.
    Boumil MM; Curfman GD
    N Engl J Med; 2013 Aug; 369(8):696-7. PubMed ID: 23923990
    [No Abstract]   [Full Text] [Related]  

  • 38. Federal pre-emption under the Food, Drug & Cosmetic Act from Medtronic, Inc. v. Lohr; Pliva. Inc. v. Mensing.
    Ball FR
    Health Care Law Mon; 2011 Sep; 2011(9):2-8. PubMed ID: 21949984
    [No Abstract]   [Full Text] [Related]  

  • 39. The learned intermediary doctrine: past, present and future.
    Alsobrook HB
    Leg Med; 1994; ():269-80. PubMed ID: 7830482
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug and device litigation in the 21st century.
    Svitak LS; Goss PJ
    Spec Law Dig Health Care Law; 2001 Nov; (271):9-36. PubMed ID: 11802352
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.